EP2147679A3

Compositions and methods for modulating blood-brain barrier transport

Abstract

This invention provides conjugates of therapeutic or active agents with melanotransferrin or with other ligands of a melanotransferrin receptor, melanotransferrin receptor modulators, and related compositions and methods for modulating blood-brain barrier transport by providing methods of screening and selecting such conjugates, ligands, and modulators in vitro and in vivo, and methods of use of such conjugates, modulators and ligands in diagnosis and the treatment of diseases, including particularly diseases of the central nervous system or lysosomal storage diseases.

Term

Term ended

Projected expiry passed 25 July 2022, 4.2 years ago.

  1. Priority
  2. Filed
  3. Published
  4. Projected expiry
  5. Today

Every citation, both ways

Citations
DocumentRelationOfficeCategoryCited duringRelevant claims
WO0004926A2CitesWorld Intellectual Property Organization (WIPO)XSearch report1-15
WO0071714A2CitesWorld Intellectual Property Organization (WIPO)ASearch report1-15
US6156311ACitesUnited States of AmericaASearch report1-15
SCHWARZ HANS PETER ET AL: "Involvement of low-density lipoprotein receptor-related protein (LRP) in the clearance of factor VIII in von Willebrand factor-deficient mice", 1 March 2000, BLOOD, VOL. 95, NR. 5, PAGE(S) 1703-1708, ISSN: 0006-4971, XP002564959Non-patentSearch report